Latest news
Explore more
Swiss biotech firm Mabylon AG raises €31.8M to advance peanut allergy antibody MY006
The funds are provided by Mabylon’s existing private investors, with the major investment coming from former management and board members of Roche.
London-based gametech startup TILKI raises $2.2M led by Twin Path Ventures
The pre-seed round was led by Twin Path Ventures, with participation from Atlas AI^VB Fund I, XTX Ventures, and SFC Capital.
Swedish energy tech firm Aira secures €150M to drive heating electrification across Europe
Aira secured €150 million in equity financing from existing investors, including Altor, Kallskär, Kinnevik, Lingotto, and Temasek.